20. April 2016 von

DGAP-News: Formycon AG: Formycon ends 2015 fiscal year with successful results

Formycon AG: DGAP-News: Formycon AG / Key word(s): Final Results/Forecast Formycon AG: Formycon ends 2015 fiscal year with successful results 20.04.2016 / 07:31 The issuer is solely responsible for the content of this announcement. Press Release // April …

Das könnte Sie interessieren

  1. DGAP-News: Formycon AG: Formycon Publishes Figures for the First Quarter of 2016
  2. DGAP-News: Formycon AG: Formycon discloses details on second pipeline product – FYB203 is a biosimilar for Eylea (aflibercept)
  3. DGAP-News: Formycon AG: Formycon and bioeq enroll first patient in pivotal phase III study with biosimilar ranibizumab (FYB201)

Comments are closed.